About the journal
- Journal Facts
- Journal Scope and Content
- Instructions for Submission
- AAI Annual Meeting Abstracts
- AAI Disclaimer
Journal Facts
- Publisher: The Journal of Immunology (The JI) is owned by The American Association of Immunologists, Inc.
- Editor-in-Chief: Gail A. Bishop, Ph.D., [email protected]
- Editorial Board: The Journal of Immunology Editorial Board. All Editors are practicing scientists.
- Impact factor:
- Two-year: 3.6 (2023 Journal Citation Reports)
- Five-year: 4.2 (2023 Journal Citation Reports)
- Cited Half-Life: 14.3 years (2023)
- Publication schedule: Monthly
- Average time from submission to initial decision (full-length manuscripts): 39 days (2023)
- Acceptance rate: 50% for full-length articles, 67% for Cutting Edge articles (2023)
- Online ISSN 1550-6606; Print ISSN 0022-1767
Journal Scope and Content
- Full-Length Articles
- Brief Reviews
- Cutting Edge Articles
- Immunology Notes and Resources
- Letters to the Editor
- Pillars of Immunology
- Translating Immunology
Full-Length Articles
The JI publishes peer-reviewed manuscripts describing novel findings in all areas of experimental immunology, including both basic and clinical studies.
Articles are published in the following sections:
- Allergy and Other Hypersensitivities
- Antigen Recognition and Responses
- Autoimmunity
- Clinical and Human Immunology: Manuscripts submitted to the Clinical and Human Immunology section will be reviewed mindful of the limitations in sample size and depth of mechanistic analyses that may be inherent to these types of studies.
- Immune Regulation
- Immune System Development
- Immunogenetics
- Immunotherapy and Vaccines
- Infectious Disease and Host Response
- Innate Immunity and Inflammation
- Molecular and Structural Immunology
- Mucosal Immunology
- Systems Immunology: Manuscripts submitted to the “Systems Immunology” section should center on analyses of novel large data sets, generated by the authors, which will serve as useful resources for future work in the field. The authors’ informatics analyses should allow them to draw concrete conclusions, supported by the data, about the biology of the system(s) under study. Alternatively, manuscripts may describe a novel method of data analysis, which could be applied to publicly available data sets. The latter type of manuscript must convincingly demonstrate the utility of the new analysis method to reveal novel biological insights about the system(s) under study. However, it is not necessary for either type of manuscript to include definitive mechanistic analysis or experiments beyond those necessary for the acquisition of reproducible and meaningful data sets.
- Transplantation
- Tumor Immunology
- Novel Immunological Methods (See Editorial): Manuscripts submitted to the “Systems Immunology” section should center on analyses of novel large data sets, generated by the authors, which will serve as useful resources for future work in the field. The authors’ informatics analyses should allow them to draw concrete conclusions, supported by the data, about the biology of the system(s) under study. Alternatively, manuscripts may describe a novel method of data analysis, which could be applied to publicly available data sets. The latter type of manuscript must convincingly demonstrate the utility of the new analysis method to reveal novel biological insights about the system(s) under study. However, it is not necessary for either type of manuscript to include definitive mechanistic analysis or experiments beyond those necessary for the acquisition of reproducible and meaningful data sets.
Cutting Edge Articles
Cutting Edge is the rapid publication section of The JI, presenting reports describing significant advances. Manuscripts submitted for consideration in this section should present scientifically sound and novel research in a clear and concise fashion, and contain conclusions of unusual interest to immunologists that are justified from the data presented. Chief criteria for acceptance are scientific novelty and quality, originality, clarity, and conciseness.
Brief Reviews
The JI publishes of invited reviews regularly. These reviews are four to six journal pages, including illustrations and references. They cover a focused area on the advancing edge of immunology and provide a balanced view of current research that can be understood by researchers outside of that specialty. Authors interested in submitting a manuscript should submit a proposal, including an outline of the proposed review, by e-mail to the Editor-in-Chief. See the collected Brief Reviews page.
Immunology Notes And Resources
Immunology Notes And Resources is a feature where items of general interest to the immunology community such as articles on nomenclature or other significant items that may impact scientific research. These articles are published at the discretion of the Editor-in-Chief, who may seek advice from other editors or experts in the field. Submissions can be made by e-mail to the Editor-in-Chief.
Letters to the Editor
The Editor-in-Chief invites brief letters (250 words or less) of general interest, commenting on work published in The JI within the previous 3 months. The authors of the original work will be invited to respond, and both the original letter and the authors' response will be published together. If you are interested in commenting on a published article, e-mail the Editor-in-Chief.
Pillars of Immunology
In the first issue of each month, The JI publishes an invited commentary discussing the impact of a seminal paper on the field. PillarTalk interviews can be found here. Suggestions for significant articles may be made by e-mail to the Editor-in-Chief.
Pillars of Immunology commentaries represent the perspectives of their authors and are not meant to serve as definitive historical documents.
Translating Immunology
These invited articles highlight immunological discoveries that have led to a treatment, drug, or diagnostic device.
Contact information
The Journal of Immunology
The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650
Rockville, MD 20852
301-634-7197 phone
Email: [email protected]
